Targeting histamine H4 receptor improves anti-tumoral response in a murine model of breast cancer
BackgroundBreast cancer is one of the most common malignant tumors in women worldwide. Histamine (HIS) has been associated with either pro-tumor or anti-tumor effects, depending on the receptor evaluated. It exerts its physiological and pharmacological…